NasdaqCM - Nasdaq Real Time Price USD

HeartSciences Inc. (HSCS)

3.5600
+0.0281
+(0.80%)
As of 2:33:07 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
0
18.6000
5.1500
14.3730
25.6040
Cost of Revenue
0
6.0810
2.7960
7.8900
10.6650
Gross Profit
0
12.5190
2.3540
6.4830
14.9390
Operating Expense
8,311.9620
6,318.2890
6,115.3180
4,715.8820
2,583.0670
Operating Income
-8,311.9620
-6,305.7700
-6,112.9640
-4,709.3990
-2,568.1280
Net Non Operating Interest Income Expense
-340.5380
-354.0800
-243.1740
-371.6190
-132.4540
Other Income Expense
135.4370
54.6420
1.8480
252.7580
248.4120
Pretax Income
-8,517.0630
-6,605.2080
-6,354.2900
-4,828.2600
-2,452.1700
Net Income Common Stockholders
-8,517.0630
-6,605.2080
-6,354.2900
-4,828.2600
-2,452.1700
Diluted NI Available to Com Stockholders
-8,517.0630
-6,605.2080
-6,354.2900
-4,828.2600
-2,452.1700
Basic EPS
-7.61
-19.00
-80.00
-59.52
-30.49
Diluted EPS
-7.61
-19.00
-80.00
-59.52
-30.49
Basic Average Shares
833.6900
352.5200
79.5060
81.1210
80.4230
Diluted Average Shares
833.6900
352.5200
79.5060
81.1210
80.4230
Total Operating Income as Reported
-8,311.9620
-6,305.7700
-6,112.9640
-4,709.3990
-2,566.4650
Total Expenses
8,311.9620
6,324.3700
6,118.1140
4,723.7720
2,593.7320
Net Income from Continuing & Discontinued Operation
-8,517.0630
-6,605.2080
-6,354.2900
-4,828.2600
-2,452.1700
Normalized Income
-8,517.0630
-6,605.2080
-6,354.2900
-5,078.4600
-2,704.0330
Interest Expense
340.5380
354.0800
243.1740
371.6190
132.4540
Net Interest Income
-340.5380
-354.0800
-243.1740
-371.6190
-132.4540
EBIT
-8,176.5250
-6,251.1280
-6,111.1160
-4,456.6410
-2,319.7160
EBITDA
-8,049.8690
-6,155.9950
-5,975.6630
-4,430.0750
-2,286.1050
Reconciled Cost of Revenue
0
6.0810
2.7960
7.8900
10.6650
Reconciled Depreciation
126.6560
95.1330
135.4530
26.5660
33.6110
Net Income from Continuing Operation Net Minority Interest
-8,517.0630
-6,605.2080
-6,354.2900
-4,828.2600
-2,452.1700
Total Unusual Items Excluding Goodwill
0
--
0
250.2000
251.8630
Total Unusual Items
0
--
0
250.2000
251.8630
Normalized EBITDA
-8,049.8690
-6,155.9950
-5,975.6630
-4,680.2750
-2,537.9680
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
4/30/2021 - 6/16/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers